Skip to content
FDA.report
Public FDA data
NDC
RxNorm
DailyMed
Applications
GUDID
GMDN
PMA
PMN
MAUDE
Recalls
Search FDA.report
Search
Home
DailyMed
product-concept
c09e7fc3-90f5-4f9d-96f4-e1a857de4102
AMINOLEVULINIC ACID HYDROCHLORIDE - Food and Drug Administration
Set ID
c09e7fc3-90f5-4f9d-96f4-e1a857de4102
Type
Indexing - product concept
Effective date
2023-07-18
Version
1
Source
DailyMed source
Mapped DailyMed Labels
#
Label, Relation, Manufacturer table
Label
Relation
Manufacturer
Effective
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Product name
Biofrontera Inc. | Glaropharm AG
2026-10-13
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Product name
Biofrontera Inc. | Glaropharm AG
2026-09-25
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Product name
Biofrontera Inc. | Glaropharm AG
2026-09-17
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Product name
Biofrontera Inc. | Glaropharm AG
2026-08-26
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Product name
Biofrontera Inc. | Glaropharm AG
2026-07-23
These highlights do not include all the information needed to use GLEOLAN safely and effectively. See full prescribing information for GLEOLAN. GLEOLAN ® (aminolevulinic acid hydrochloride) for oral solution Initial U.S. Approval: [1999]
Product name
NX DEVELOPMENT CORP
2026-01-29
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Product name
Biofrontera Inc. | Glaropharm AG
2025-12-22
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Product name
Biofrontera Inc. | Glaropharm AG
2025-12-18
These highlights do not include all the information needed to use carvedilol tablets safely and effectively. See full prescribing information for carvedilol tablets. Initial U.S. Approval: 1995
Product name
Proficient Rx LP
2025-12-01
These highlights do not include all the information needed to use LEVULAN ® KERASTICK ® safely and effectively. See full prescribing information for LEVULAN KERASTICK. LEVULAN KERASTICK (aminolevulinic acid HCl) for Topical Solution, 20% Initial U.S. Approval: 1999
Product name
Sun Pharmaceutical Industries, Inc
2024-09-12
These highlights do not include all the information needed to use carvedilol tablets safely and effectively. See full prescribing information for carvedilol tablets. Initial U.S. Approval: 1995
Product name
Proficient Rx LP
2024-07-01
These highlights do not include all the information needed to use GLEOLAN safely and effectively. See full prescribing information for GLEOLAN. GLEOLAN® (aminolevulinic acid hydrochloride) for oral solution Initial U.S. Approval: [1999]
Product name
Medexus Pharma, Inc. | NX Development Corp
2024-05-03
Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% For Topical Use Only Not for Opthalmic Use
Product name
DUSA
2006-10-08
Related NDC Packages
#
NDC, DailyMed label, Manufacturer table
NDC
DailyMed label
Manufacturer
59137-231
These highlights do not include all the information needed to use GLEOLAN safely and effectively. See full prescribing information for GLEOLAN. GLEOLAN® (aminolevulinic acid hydrochloride) for oral solution Initial U.S. Approval: [1999]
Medexus Pharma, Inc. | NX Development Corp
59137-231-01
These highlights do not include all the information needed to use GLEOLAN safely and effectively. See full prescribing information for GLEOLAN. GLEOLAN® (aminolevulinic acid hydrochloride) for oral solution Initial U.S. Approval: [1999]
Medexus Pharma, Inc. | NX Development Corp
63187-424
These highlights do not include all the information needed to use carvedilol tablets safely and effectively. See full prescribing information for carvedilol tablets. Initial U.S. Approval: 1995
Proficient Rx LP
63187-424-30
These highlights do not include all the information needed to use carvedilol tablets safely and effectively. See full prescribing information for carvedilol tablets. Initial U.S. Approval: 1995
Proficient Rx LP
63187-424-60
These highlights do not include all the information needed to use carvedilol tablets safely and effectively. See full prescribing information for carvedilol tablets. Initial U.S. Approval: 1995
Proficient Rx LP
63187-570
These highlights do not include all the information needed to use carvedilol tablets safely and effectively. See full prescribing information for carvedilol tablets. Initial U.S. Approval: 1995
Proficient Rx LP
63187-570-60
These highlights do not include all the information needed to use carvedilol tablets safely and effectively. See full prescribing information for carvedilol tablets. Initial U.S. Approval: 1995
Proficient Rx LP
63187-570-90
These highlights do not include all the information needed to use carvedilol tablets safely and effectively. See full prescribing information for carvedilol tablets. Initial U.S. Approval: 1995
Proficient Rx LP
67308-101
Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% For Topical Use Only Not for Opthalmic Use
DUSA
67308-101
These highlights do not include all the information needed to use LEVULAN ® KERASTICK ® safely and effectively. See full prescribing information for LEVULAN KERASTICK. LEVULAN KERASTICK (aminolevulinic acid HCl) for Topical Solution, 20% Initial U.S. Approval: 1999
Sun Pharmaceutical Industries, Inc
67308-101-01
Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% For Topical Use Only Not for Opthalmic Use
DUSA
67308-101-01
These highlights do not include all the information needed to use LEVULAN ® KERASTICK ® safely and effectively. See full prescribing information for LEVULAN KERASTICK. LEVULAN KERASTICK (aminolevulinic acid HCl) for Topical Solution, 20% Initial U.S. Approval: 1999
Sun Pharmaceutical Industries, Inc
67308-101-02
These highlights do not include all the information needed to use LEVULAN ® KERASTICK ® safely and effectively. See full prescribing information for LEVULAN KERASTICK. LEVULAN KERASTICK (aminolevulinic acid HCl) for Topical Solution, 20% Initial U.S. Approval: 1999
Sun Pharmaceutical Industries, Inc
67308-101-06
Levulan® Kerastick® (aminolevulinic acid HCl) for Topical Solution, 20% For Topical Use Only Not for Opthalmic Use
DUSA
67308-101-06
These highlights do not include all the information needed to use LEVULAN ® KERASTICK ® safely and effectively. See full prescribing information for LEVULAN KERASTICK. LEVULAN KERASTICK (aminolevulinic acid HCl) for Topical Solution, 20% Initial U.S. Approval: 1999
Sun Pharmaceutical Industries, Inc
68382-092
These highlights do not include all the information needed to use carvedilol tablets safely and effectively. See full prescribing information for carvedilol tablets. Initial U.S. Approval: 1995
Proficient Rx LP
68382-093
These highlights do not include all the information needed to use carvedilol tablets safely and effectively. See full prescribing information for carvedilol tablets. Initial U.S. Approval: 1995
Proficient Rx LP
70621-101
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Biofrontera Inc. | Glaropharm AG
70621-101-01
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Biofrontera Inc. | Glaropharm AG
70621-101-03
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Biofrontera Inc. | Glaropharm AG
70621-101-10
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Biofrontera Inc. | Glaropharm AG
70621-101-20
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Biofrontera Inc. | Glaropharm AG
70621-101-30
These highlights do not include all the information needed to use AMELUZ safely and effectively. See full prescribing information for AMELUZ. AMELUZ ® (aminolevulinic acid hydrochloride) topical gel Initial U.S. Approval: 1999
Biofrontera Inc. | Glaropharm AG
71469-231
These highlights do not include all the information needed to use GLEOLAN safely and effectively. See full prescribing information for GLEOLAN. GLEOLAN ® (aminolevulinic acid hydrochloride) for oral solution Initial U.S. Approval: [1999]
NX DEVELOPMENT CORP
71469-231-01
These highlights do not include all the information needed to use GLEOLAN safely and effectively. See full prescribing information for GLEOLAN. GLEOLAN ® (aminolevulinic acid hydrochloride) for oral solution Initial U.S. Approval: [1999]
NX DEVELOPMENT CORP